What the six lenses say about ASTRAZEN — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How ASTRAZEN’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | -0.8pp | -0.2pp | -11.7pp | -20.7pp | -18.5pp | -20.2pp |
Nifty 500 Broad-market baseline | -0.9pp | -0.2pp | -12.7pp | -22.3pp | -24.3pp | -25.5pp |
Sector Own-sector index | — | — | -15.6pp | -28.4pp | -37.4pp | -46.3pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
ASTRAZEN daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
ASTRAZEN ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
No quarterly financials available.
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding ASTRAZEN (10)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| Nippon India Small Cap Gr | 0.68% | 78,957 | |
| Nippon India Small Cap Gr Bns | 0.68% | 78,957 | |
| Nippon India Small Cap Dir Bns | 0.68% | 78,957 | |
| Bandhan Large & Mid Cap Gr | 0.60% | 19,777 | |
| Nippon India Pharma Bns | 0.55% | 9,279 | |
| Nippon India Pharma Gr | 0.55% | 9,279 | |
| ICICI Pru Pharma Healthcare Diag Gr | 1.86% | 6,803 | |
| Bandhan Agrsv Hyb Reg Gr | 0.95% | 2,410 | |
| Bandhan Large Cap Gr | 0.64% | 2,145 | |
| Baroda BNP Paribas Small Cap Reg Gr | 2.03% | 1,288 |
ETFs holding ASTRAZEN (0)
No tracked ETF holds ASTRAZEN ≥0.5%.